Prous Institute for Biomedical Research

Prous Institute for Biomedical Research is a private research organization based in Barcelona, Spain, dedicated to the discovery and development of novel therapeutic entities. The company utilizes its proprietary Symmetry platform, a computational drug discovery technology that integrates chemical, biological, and clinical data to identify and optimize new drug candidates. Their internal research programs primarily focus on neurodegenerative diseases, oncology, and inflammatory disorders, with a particular emphasis on multi-target small molecules. By combining in silico modeling with medicinal chemistry and biological validation, the Institute aims to streamline the transition from discovery to clinical development. Prous Institute maintains a hybrid business model, advancing its own pipeline while engaging in strategic partnerships and licensing agreements with global pharmaceutical companies.